These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 34560862)

  • 1. Clinical connectivity map for drug repurposing: using laboratory results to bridge drugs and diseases.
    Wen Q; Liu R; Zhang P
    BMC Med Inform Decis Mak; 2021 Sep; 21(Suppl 8):263. PubMed ID: 34560862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
    Jang D; Lee S; Lee J; Kim K; Lee D
    J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks.
    Nam Y; Lucas A; Yun JS; Lee SM; Park JW; Chen Z; Lee B; Ning X; Shen L; Verma A; Kim D
    J Transl Med; 2023 Jun; 21(1):415. PubMed ID: 37365631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Machine-Learning-Based Drug Repurposing Approach Using Baseline Regularization.
    Kuang Z; Bao Y; Thomson J; Caldwell M; Peissig P; Stewart R; Willett R; Page D
    Methods Mol Biol; 2019; 1903():255-267. PubMed ID: 30547447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new computational drug repurposing method using established disease-drug pair knowledge.
    Saberian N; Peyvandipour A; Donato M; Ansari S; Draghici S
    Bioinformatics; 2019 Oct; 35(19):3672-3678. PubMed ID: 30840053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-tiered unsupervised clustering approach for drug repositioning through heterogeneous data integration.
    Hameed PN; Verspoor K; Kusljic S; Halgamuge S
    BMC Bioinformatics; 2018 Apr; 19(1):129. PubMed ID: 29642848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case.
    Huang LC; Soysal E; Zheng W; Zhao Z; Xu H; Sun J
    BMC Syst Biol; 2015; 9 Suppl 4(Suppl 4):S2. PubMed ID: 26100720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Analytical Review of Computational Drug Repurposing.
    Sadeghi SS; Keyvanpour MR
    IEEE/ACM Trans Comput Biol Bioinform; 2021; 18(2):472-488. PubMed ID: 31403439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Noncancer Drug Effects on Survival in Electronic Health Records of Patients With Cancer: A New Paradigm for Drug Repurposing.
    Wu Y; Warner JL; Wang L; Jiang M; Xu J; Chen Q; Nian H; Dai Q; Du X; Yang P; Denny JC; Liu H; Xu H
    JCO Clin Cancer Inform; 2019 May; 3():1-9. PubMed ID: 31141421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics and Systems Pharmacology Approaches to Repurposing Drugs in the Wake of Global Health Burden.
    Bai JPF
    J Pharm Sci; 2016 Oct; 105(10):3007-3012. PubMed ID: 27522921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality.
    Xu H; Aldrich MC; Chen Q; Liu H; Peterson NB; Dai Q; Levy M; Shah A; Han X; Ruan X; Jiang M; Li Y; Julien JS; Warner J; Friedman C; Roden DM; Denny JC
    J Am Med Inform Assoc; 2015 Jan; 22(1):179-91. PubMed ID: 25053577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REPRODUCIBLE DRUG REPURPOSING: WHEN SIMILARITY DOES NOT SUFFICE.
    Guney E
    Pac Symp Biocomput; 2017; 22():132-143. PubMed ID: 27896969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting associations among drugs, targets and diseases by tensor decomposition for drug repositioning.
    Wang R; Li S; Cheng L; Wong MH; Leung KS
    BMC Bioinformatics; 2019 Dec; 20(Suppl 26):628. PubMed ID: 31839008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating gene expression and clinical data to identify drug repurposing candidates for hyperlipidemia and hypertension.
    Wu P; Feng Q; Kerchberger VE; Nelson SD; Chen Q; Li B; Edwards TL; Cox NJ; Phillips EJ; Stein CM; Roden DM; Denny JC; Wei WQ
    Nat Commun; 2022 Jan; 13(1):46. PubMed ID: 35013250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconciling multiple connectivity scores for drug repurposing.
    Samart K; Tuyishime P; Krishnan A; Ravi J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASGARD is A Single-cell Guided Pipeline to Aid Repurposing of Drugs.
    He B; Xiao Y; Liang H; Huang Q; Du Y; Li Y; Garmire D; Sun D; Garmire LX
    Nat Commun; 2023 Feb; 14(1):993. PubMed ID: 36813801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards drug repositioning: a unified computational framework for integrating multiple aspects of drug similarity and disease similarity.
    Zhang P; Wang F; Hu J
    AMIA Annu Symp Proc; 2014; 2014():1258-67. PubMed ID: 25954437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing for Newly Emerged Diseases via Network-based Inference on a Gene-disease-drug Network.
    Qin L; Wang J; Wu Z; Li W; Liu G; Tang Y
    Mol Inform; 2022 Sep; 41(9):e2200001. PubMed ID: 35338586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Drugs for Skin Cancer.
    Khachigian LM
    Curr Med Chem; 2020; 27(42):7214-7221. PubMed ID: 31858902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.